Clinical Trials
- Endocrine System, Genetics
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (GATEWAY)
- Ages18 years - 60 years
- GenderBoth
- Alzheimer's
A Randomized, Double-Blind, Placebo controlled, Parallel-group, Multicenter Study to Assess the Efficacy and Safety of JNJ-63733657, an anti-tau Monoclonal Antibody, in Participants with Early Alzheimer's Disease
- Ages55 years - 80 years
- GenderBoth
- Alzheimer's
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
- Ages60 years - 85 years
- GenderBoth
- Alzheimer's
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)
- Ages50 years - 80 years
- GenderBoth
- Alzheimer's
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
- Ages55 years - 80 years
- GenderBoth
- Addictive Behavior
Brain Imaging and Synaptic Plasticity
- Ages21 years - 60 years
- GenderBoth
- Mental Health & Behavioral Research
Eligibility for Participation in Neuroimaging Studies
- Men's Health, Women's Health
Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923
- Ages50 years - 80 years
- GenderBoth
- Mental Health & Behavioral Research
HPA axis function in the brains of PTSD, Trauma Exposed, or Otherwise Healthy research participants utilizing PET and MRI imaging
- Ages18 years - 55 years
- GenderBoth
- Mental Health & Behavioral Research
Imaging mGluR5 and synaptic density in psychiatric disorders
- Ages18 years - 80 years
- GenderBoth